Data / Form D filings / Orion Therapeutics, Inc.
Orion Therapeutics, Inc.: Form D filings
Orion Therapeutics, Inc., a biotechnology company in Knoxville, TN, filed 2 Form D notices with the SEC between 2022 and 2024. The latest, on September 25, 2024, reports $85,000 sold of a $250,000 offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2641 OSPREY VISTA WAY, LAB 150A, Knoxville, TN, 37920
- Phone
- (865) 771-7024
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1958173
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 25, 2024 | New notice | $250,000 | $85,000 | $165,000 | 4 | Sep 10, 2024 | sec.gov |
| Dec 14, 2022 | New notice | $250,000 | $60,000 | $190,000 | 1 | Nov 30, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Deidra Kern Mountain | Director | |
| Richard Kern Fisher | Executive Officer, Director | |
| Michael Kern McCaman | Executive Officer, Director |
Other biotechnology companies in Tennessee that filed recently
- Synomis, Inc. $30,000 · Oct 30, 2026
- TM Holding Companies, Inc. $3.7 million · Oct 8, 2026
Every Form D from the week of Sep 23, 2024 · All recent filings in Tennessee · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Orion Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.